← Back to Search

Health Education + Home Monitoring for High Blood Pressure

N/A
Recruiting
Led By Erin Westfall, DO
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 weeks, 3 months
Awards & highlights

Study Summary

This trial hopes to lessen differences in how Somali people in Mankato are treated for high blood pressure.

Who is the study for?
This trial is for non-pregnant members of the Greater Mankato Somali community who frequent mosques or Halal stores. It aims to help those within this group manage high blood pressure better.Check my eligibility
What is being tested?
The study is testing whether health education and using home blood pressure monitors can reduce hypertension in the targeted population. Participants will receive these interventions and their impact on managing high blood pressure will be observed.See study design
What are the potential side effects?
Since the interventions include health education and monitoring with a home device, there are no direct medical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 weeks, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 weeks, 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Primary Care Provider status
Changes in systolic and diastolic blood pressure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment2 Interventions
Participants will be given access to health education, home blood pressure monitor, and referral to a primary care provider.
Group II: Control GroupActive Control1 Intervention
Participants receive referrals only to a primary care provider (PCP) for blood pressure monitoring.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4010

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,215 Previous Clinical Trials
3,767,143 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,259 Total Patients Enrolled
Erin Westfall, DOPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
24 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies in this research project?

"Affirmative. According to information hosted on clinicaltrials.gov, the study is actively recruiting patients with an initial listing published in February of 2023 and a most recent update occurring May 15th of that same year. 100 individuals are being sought from one location for this trial."

Answered by AI

What is the enrolment size of this trial?

"Affirmative. Clinicaltrials.gov data suggests that recruitment for this trial is in full swing, having been posted on February 21st 2023 and last updated on May 15th 2023. The study seeks a total of 100 participants from one specific site."

Answered by AI

Who else is applying?

What site did they apply to?
Erin Westfall
What portion of applicants met pre-screening criteria?
Met criteria
~12 spots leftby Jun 2024